Haisco Pharmaceutical Group Co., Ltd.
002653
Peringkat dalam Saham
#2093
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Harga Saham
$8.65
Kapitalisasi Pasar
$9.87B
Perubahan (1 hari)
4.52%
Perubahan (1 tahun)
19.00%
Negara
CN
Perdagangan Haisco Pharmaceutical Group Co., Ltd. (002653)
Kategori
Healthcare
Margin Operasi untuk Haisco Pharmaceutical Group Co., Ltd. (002653)
Margin Operasi per October 2026 TTM: 13.82%
Menurut laporan keuangan dan harga saham terbaru dari Haisco Pharmaceutical Group Co., Ltd., margin operasi saat ini (TTM) adalah 13.82%. Pada akhir 2023, margin operasi perusahaan adalah 9.35%.
Riwayat margin operasi untuk Haisco Pharmaceutical Group Co., Ltd. dari 2008 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Mengubah |
|---|---|---|
| 2026 (TTM) | 13.82% | 1.32% |
| 2024 | 13.64% | 45.88% |
| 2023 | 9.35% | -22.66% |
| 2022 | 12.09% | -34.54% |
| 2021 | 18.47% | -12.01% |
| 2020 | 20.99% | 51.12% |
| 2019 | 13.89% | 46.98% |
| 2018 | 9.45% | -34.05% |
| 2017 | 14.33% | -40.86% |
| 2016 | 24.23% | -27.48% |
| 2015 | 33.41% | -11.00% |
| 2014 | 37.54% | -19.25% |
| 2013 | 46.49% | 6.90% |
| 2012 | 43.49% | -8.52% |
| 2011 | 47.54% | -4.88% |
| 2010 | 49.98% | -10.09% |
| 2009 | 55.59% | -3.81% |
| 2008 | 57.79% | 0.00% |
Margin Operasi untuk perusahaan sejenis atau pesaing
| Perusahaan | Margin Operasi | Perbedaan Margin Operasi | Negara |
|---|---|---|---|
| 38.59% | -97.21% |
US
|
|
| -149.01% | -110.78% |
US
|
|
| 25.57% | -98.15% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -97.92% |
NL
|
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.